Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single Centre, Open-label, Randomised, Single Dose, Six Period, Reference Replicate, Crossover Study to Evaluate the Bioavailability of MED2005

Trial Profile

A Single Centre, Open-label, Randomised, Single Dose, Six Period, Reference Replicate, Crossover Study to Evaluate the Bioavailability of MED2005

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitroglycerin (Primary) ; Nitroglycerin; Nitroglycerin
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics; Registrational
  • Acronyms FM58
  • Sponsors Futura Medical
  • Most Recent Events

    • 09 Jul 2019 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 02 Jul 2019 Status changed from recruiting to completed.
    • 09 Nov 2018 According to a Futura Medical media release, data from this study will be presented at the 9th Annual Fall Scientific Meeting of SMSNA, (Nov 2018).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top